Tyrosinase maturation and pigment expression in B16 melanoma: relation to theophylline treatment and intracellular cyclic AMP.
We have studied the effects of theophylline treatment on pigmentation characteristics and growth of two B16 melanoma cell lines, HFH-18 and P/140. Cell counts of control and theophylline-treated cultures confirmed that the drug inhibits cell growth. Light and electron microscope cytochemistry with the L-dopa reaction indicated that the two cell lines differ in their ability to transfer Golgi-associated tyrosinase to developing premelanosomes. The results of these experiments, considered with results of electrophoretic analyses and activity measurements by the Pomerantz method, also provide evidence that increased tyrosinase synthesis occurs in response to theophylline treatment. In addition, results indicate that theophylline induces changes in the rate of synthetic or degradative posttranslational modification of tyrosinase. Measurements of intracellular cyclic AMP levels by radioimmunoassay in control cultures and in theophylline- and alpha-MSH-treated cultures were made. Although the hormone induced spectacular increases in cyclic AMP levels, theophylline produced no detectable change. These results indicate that theophylline differs from alpha-MSH because theophylline-induced changes in pigmentation may not require the participation of intracellular cyclic AMP.
D000818:Animals; D004156:Catechol Oxidase / Q000096:biosynthesis*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D000242:Cyclic AMP / Q000378:metabolism*; D004790:Enzyme Induction / Q000187:drug effects; D007700:Kinetics; D008545:Melanoma / Q000378:metabolism* / Q000648:ultrastructure; D051379:Mice; D014442:Monophenol Monooxygenase / Q000096:biosynthesis*; D010860:Pigments, Biological / Q000378:metabolism*; D013806:Theophylline / Q000494:pharmacology
D010860:Pigments, Biological; D013806:Theophylline; D000242:Cyclic AMP; D004156:Catechol Oxidase; D014442:Monophenol Monooxygenase